Zobrazeno 1 - 10
of 270
pro vyhledávání: '"Karl L. Insogna"'
Publikováno v:
International Journal of Women's Dermatology, Vol 7, Iss 5, Pp 545-551 (2021)
Glucocorticoid-induced osteoporosis (GIOP) is a frequently encountered and serious side effect of glucocorticoid use. Bone loss leading to an increased risk for fracture occurs early in the use of glucocorticoids, yet patients at risk for this compli
Externí odkaz:
https://doaj.org/article/c56d1f67b63049baa7c4e87e799843cf
Autor:
Peter Kamenický, Anthony A. Portale, Tom Carpenter, Karine Briot, Erik A. Imel, Thomas Weber, Pisit Pitukcheewanont, Hae Il Cheong, Suzanne Jan de Beur, Yasuo Imanishi, Nobuaki Ito, Robin Lachmann, Hiroyuki Tanaka, Farzana Perwad, Lin Zhang, Alison Skrinar, Linda Rees, Karl L. Insogna
Publikováno v:
Bone Reports, Vol 13, Iss , Pp 100654- (2020)
Externí odkaz:
https://doaj.org/article/8231e2f3c59e4b729a9ca6cb8b3de4dc
Autor:
Evelyn Hsieh, Qin Wang, Renzhi Zhang, Xin Niu, Weibo Xia, Liana Fraenkel, Karl L. Insogna, Jing Li, Jennifer S. Smith, Chunwu Zhou, You-lin Qiao, Pin Zhang
Publikováno v:
BMC Cancer, Vol 18, Iss 1, Pp 1-9 (2018)
Abstract Background Breast cancer survivors are at high risk for fracture due to cancer treatment-induced bone loss, however, data is scarce regarding the scope of this problem from an epidemiologic and health services perspective among Chinese women
Externí odkaz:
https://doaj.org/article/a85f813611fa4486a05b10394e8932c6
Autor:
Patricia R. Peter, MD, Catherine A. Brownstein, PhD, Gang-Qing Yao, MD, Elizabeth A. Olear, MS, MA, Christine A. Simpson, MS, MT (ASCP), Pankaj B. Agrawal, MD, MMSC, Thomas O. Carpenter, MD, Karl L. Insogna, MD
Publikováno v:
AACE Clinical Case Reports, Vol 2, Iss 4, Pp ee278-ee283 (2016)
ABSTRACT: Objective: Rickets can be caused by a wide variety of underlying nutritional deficiencies or genetic defects. There is significant overlap in the clinical presentations of the various forms of rickets and the risk for misdiagnosis is great.
Externí odkaz:
https://doaj.org/article/8ea09908ee7b4aa186f63a6000ae5924
Autor:
Violeta Stojkovic, Christine A. Simpson, Rebecca R. Sullivan, Anna Maria Cusano, Jane E. Kerstetter, Anne M. Kenny, Karl L. Insogna, Jessica D. Bihuniak
Publikováno v:
Nutrients, Vol 9, Iss 5, p 484 (2017)
Controversy exists as to whether high glycemic index/glycemic load (GI/GL) diets increase the risk of chronic inflammation, which has been postulated as a pathogenic intermediary between such diets and age-related alterations in body composition and
Externí odkaz:
https://doaj.org/article/b4513b8234a3494bba5c352179ea38ec
Autor:
Salvatore Minisola, Andrew Arnold, Zhanna Belaya, Maria Luisa Brandi, Bart L. Clarke, Fadil M. Hannan, Lorenz C. Hofbauer, Karl L. Insogna, André Lacroix, Uri Liberman, Andrea Palermo, Jessica Pepe, René Rizzoli, Robert Wermers, Rajesh V. Thakker
Publikováno v:
Journal of Bone and Mineral Research. 37:2315-2329
In this narrative review, we present data gathered over four decades (1980-2020) on the epidemiology, pathophysiology and genetics of primary hyperparathyroidism (PHPT). PHPT is typically a disease of postmenopausal women, but its prevalence and inci
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e1df3542f953e9d774938a2ec80942d8
https://doi.org/10.1002/jbmr.4665
https://doi.org/10.1002/jbmr.4665
Autor:
Anna Maria Santoro, Christine A. Simpson, Elaine Cong, Andrea Haas, Rebecca R. Sullivan, Stephen Parziale, Yanhong Deng, Karl L. Insogna
Publikováno v:
Menopause (New York, N.Y.). 29(10)
The aim of this study was to examine the effect of either conjugated equine estrogen or transdermal estradiol on vitamin D metabolism in postmenopausal women.Twenty-five women from the Kronos Early Estrogen Prevention Study who were randomized to con
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f918ed0aaf46192af5e1f0ead9b9bf7e
https://pubmed.ncbi.nlm.nih.gov/35969885
https://pubmed.ncbi.nlm.nih.gov/35969885
Autor:
Diana Athonvarangkul, Karl L. Insogna
Publikováno v:
Calcified Tissue International. 108:143-157
FGF23 is a hormone produced by osteocytes in response to an elevation in the concentration of extracellular phosphate. Excess production of FGF23 by bone cells, or rarely by tumors, is the hormonal basis for several musculoskeletal syndromes characte
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e37cee8d269ed15a6a5eff2f220358c5
https://doi.org/10.1007/s00223-020-00705-3
https://doi.org/10.1007/s00223-020-00705-3
Publikováno v:
Calcif Tissue Int
Sphingosine-1-phosphate (S1P) is an anabolic clastokine. Colony Stimulating Factor 1 (CSF1) induces expression of the rate limiting enzyme required for S1P synthesis, sphingosine kinase 1 (SPHK1) in bone in vivo, and in osteoclasts in vitro. To study
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ac6224ec20bd25881016e77fb780dc8
https://doi.org/10.1007/s00223-020-00685-4
https://doi.org/10.1007/s00223-020-00685-4
Autor:
Anika K. Anam, Karl L. Insogna
Publikováno v:
The Medical clinics of North America. 105(6)
Osteoporosis is a metabolic bone disease characterized by low bone mass and microarchitectural deterioration of bone tissue leading to an increased risk of fragility fractures. Central dual-energy X-ray absorptiometry measurements are the gold standa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a22bedcb2a97611da824f5406d60a102
https://pubmed.ncbi.nlm.nih.gov/34688418
https://pubmed.ncbi.nlm.nih.gov/34688418